SCHEMBL1728764

SCHEMBL1728764

CN(C)CCOc1ccc(-n2ccn(-c3ccc(Oc4cccc(C(F)(F)F)c4)cc3)c2=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GALR3 O60755 4/20 0.52
LTA4H P09960 2/20 0.51
MCHR1 Q99705 1/20 0.48
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
CACNA1B Q00975 5/20 0.44
SCN9A Q15858 1/20 0.42
CACNA1H O95180 2/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1727854 0.86 LTA4H (0.52) LTA4HMCHR1KDM4EALDH1A1CACNA1B
SCHEMBL1728528 0.86 LTA4H (0.52) LTA4HMCHR1KDM4EALDH1A1CACNA1B
SCHEMBL1728669 0.85 LTA4H (0.68) LTA4HMCHR1KDM4EALDH1A1CACNA1B
SCHEMBL1728647 0.85 KDM4E (0.55) LTA4HMCHR1KDM4EALDH1A1CACNA1B
SCHEMBL1727319 0.82 LTA4H (0.51) LTA4HMCHR1KDM4ECACNA1BCACNA1H
SCHEMBL1729490 0.81 MAPK14 (0.56) LTA4HMCHR1ALDH1A1
SCHEMBL6081954 0.78 MCHR1 (0.49) GALR3LTA4HMCHR1KDM4EALDH1A1
SCHEMBL1728773 0.78 CHRNB2 (0.59) LTA4HMCHR1
SCHEMBL1728527 0.78 MCHR1 (0.51) LTA4HMCHR1
SCHEMBL1728628 0.77 MCHR1 (0.51) LTA4HMCHR1KDM4ECACNA1BCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551810-B1 DIARYL-SUBSTITUTED CYCLIC UREA DERIVATIVES HAVING AN MCH-MODULATORY EFFECT SANOFI AVENTIS DEUTSCHLAND (DE) 2011-11-30 EP disclosed
US-7141561-B2 Substituted diaryl heterocycles, process for their preparation and their use as medicaments SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-11-28 US disclosed